
Clear Note Health is a cancer detection company focused on enabling early detection of high-mortality cancers through non-invasive tests. Utilizing a standard blood draw, their proprietary epigenomic platform combines biology and artificial intelligence to identify DNA-based changes indicative of cancer development. The company aims to change the patient care paradigm by providing clinicians and patients with better tools to identify cancers at more treatable stages. With a strong emphasis on R&D and clinical evidence, Clear Note Health is positioned as a leader in the liquid biopsy market, particularly for pancreatic and ovarian cancers, and operates a CLIA and CAP-accredited laboratory in San Diego, California.

Clear Note Health is a cancer detection company focused on enabling early detection of high-mortality cancers through non-invasive tests. Utilizing a standard blood draw, their proprietary epigenomic platform combines biology and artificial intelligence to identify DNA-based changes indicative of cancer development. The company aims to change the patient care paradigm by providing clinicians and patients with better tools to identify cancers at more treatable stages. With a strong emphasis on R&D and clinical evidence, Clear Note Health is positioned as a leader in the liquid biopsy market, particularly for pancreatic and ovarian cancers, and operates a CLIA and CAP-accredited laboratory in San Diego, California.